GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 745 filers reported holding GLAXOSMITHKLINE PLC in Q3 2016. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $311,000 | +234.4% | 7,137 | +221.3% | 0.08% | +151.6% |
| Q1 2019 | $93,000 | +5.7% | 2,221 | -3.9% | 0.03% | -11.4% |
| Q4 2018 | $88,000 | +1000.0% | 2,311 | +995.3% | 0.04% | +1066.7% |
| Q3 2018 | $8,000 | -11.1% | 211 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $9,000 | +12.5% | 211 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $8,000 | 0.0% | 211 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $8,000 | -96.4% | 211 | -96.2% | 0.00% | -97.1% |
| Q3 2017 | $224,000 | +5500.0% | 5,518 | +5418.0% | 0.10% | +5050.0% |
| Q2 2017 | $4,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $4,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $4,000 | -81.8% | 100 | -80.2% | 0.00% | -87.5% |
| Q3 2016 | $22,000 | +266.7% | 506 | +274.8% | 0.02% | +220.0% |
| Q1 2015 | $6,000 | 0.0% | 135 | 0.0% | 0.01% | -16.7% |
| Q4 2014 | $6,000 | – | 135 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |